Indeed, mir-378 was reported to modulate the phenotype of RMS cells through IGF1R regulation [19], whereas miR-206 over-expression reduced tumor growth in vivo by inhibiting c-MET [20]. The gene discussed is IGF1R; the disease is neoplasm.